SKYA Home Investment Highlights Valuation & Metrics Price Chart Why The Stock Moved Return vs. Risk About SKYA Interactive Breakdown Better Bets vs. SKYA Peer Outperformance Latest Trefis Analyses Trade Ideas More From Trefis Peer Comparisons FDIC Bank Data FDA Approved Drugs Data Clinical Pipeline Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Forward Guidance Insider Activity Investor Activity (13F) Trade Sentinel Investor Videos Industry Resource Links External Quote Links

    SkyAI (SKYA)

    Market Price (9/21/2026): $1.72 | Market Cap: $124.0 MilSector: Information Technology | Industry: Systems Software

    SkyAI (SKYA)

    Market Price (9/21/2026): $1.72
    Market Cap: $124.0 Mil
    Sector: Information Technology
    Industry: Systems Software

    Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

    0

    Strong revenue growth
    Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 28%

    Megatrend and thematic drivers
    Megatrends include Artificial Intelligence, and Advanced Aviation & Space. Themes include AI Software Platforms, and Drone Technology.

    Weak multi-year price returns
    2Y Excs Rtn is -40%, 3Y Excs Rtn is -75%

    Not profitable at operating income level
    Op Inc LTMOperating Income, Last Twelve Months is -19 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -10758%

    Expensive valuation multiples
    P/SPrice/Sales ratio is 704x

    Weak revenue growth
    Rev Chg QQuarterly Revenue Change % is null

    Significant share based compensation
    SBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 64053%

    Not cash flow generative
    CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -8259%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -115934%

    Yield minus risk free rate is negative
    ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -329%

    High stock price volatility
    Vol 12M is 115%

    Key risks
    SKYA key risks include [1] heavy financial dependence on its significant Solana (SOL) digital asset treasury, Show more.

    0 Strong revenue growth
    Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 28%
    1 Megatrend and thematic drivers
    Megatrends include Artificial Intelligence, and Advanced Aviation & Space. Themes include AI Software Platforms, and Drone Technology.
    2 Weak multi-year price returns
    2Y Excs Rtn is -40%, 3Y Excs Rtn is -75%
    3 Not profitable at operating income level
    Op Inc LTMOperating Income, Last Twelve Months is -19 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -10758%
    4 Expensive valuation multiples
    P/SPrice/Sales ratio is 704x
    5 Weak revenue growth
    Rev Chg QQuarterly Revenue Change % is null
    6 Significant share based compensation
    SBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 64053%
    7 Not cash flow generative
    CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -8259%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -115934%
    8 Yield minus risk free rate is negative
    ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -329%
    9 High stock price volatility
    Vol 12M is 115%
    10 Key risks
    SKYA key risks include [1] heavy financial dependence on its significant Solana (SOL) digital asset treasury, Show more.

    SKYA in ETFs

    Weight = SKYA's share of each fund

    VTI0.00%

    Valuation & Metrics

    FYE: 12/31SKYA [1]S&P 500 [2]
    REVENUE GROWTH
    LTM Revenue [3]$0.2 Mil—
    FY 2026 Sales$72.4 Mil—
    FY 2027 Sales$79.6 Mil—
    FY 2026 Sales Growth41,466.7%—
    FY 2027 Sales Growth9.9%12.9%
    EARNINGS
    LTM Net Income (GAAP) [3]$-397.5 Mil—
    FY 2026 Net Income (Non-GAAP)$0.0 Mil—
    FY 2027 Net Income (Non-GAAP)$0.0 Mil—
    FY 2027 Net Income Growth—18.1%
    FY 2026 EPS (Non-GAAP)$0.00—
    FY 2027 EPS (Non-GAAP)$0.00—
    FY 2027 EPS Growth——
    VALUATION
    FY 2026 P/S1.71.6
    FY 2027 P/S1.6—
    FY 2026 P/E—7.4
    FY 2027 P/E——

    [1] SKYA forward figures are analyst consensus for the next two fiscal years (fiscal year end 12/31). Net Income and EPS are non-GAAP (adjusted) consensus. P/S and P/E divide the current market cap by the consensus figure.
    [2] S&P 500 figures are the SPY ETF's holdings-weighted forward aggregate. P/S and P/E reflect FY1/FY2 consensus blended to the 12-month window ending 9/30/27 (~one year forward), shown when ≥90% of index weight has estimates. Growth is the aggregate next-fiscal-year vs current-fiscal-year (FY1→FY2) change. Index-level dollar Sales, Net Income and EPS are not applicable.
    [3] LTM = reported trailing-twelve-month actuals (GAAP).
    SKYAS&P 500
    REVENUE GROWTHVERY GOOD
    Rev LTM ($ Bil)0.0
    Rev Chg Q-100.0%9.3%
    Rev Chg LTM28.0%8.3%
    Rev Chg 3Y Avg28.0%5.8%
    PROFITABILITYVERY POOR
    Op Inc LTM ($ Bil)-0.0
    CFO LTM ($ Bil)-0.0
    Net Inc LTM ($ Bil)-0.4
    Op Mgn LTM-10,757.7%18.6%
    CFO/Rev LTM-8,259.4%21.8%
    Net Inc Mgn-228,220.7%13.1%
    VALUATIONVERY HIGH
    P/S714.03.1
    P/CFO-8.614.8
    P/FCF-0.619.3
    P/E-0.322.5
    STABILITYGOOD
    Debt/Equity0.000.21
    Cash/Assets0.080.07

    AI Analysis | Feedback

    MetricValueDateSource
    Global South population share85%5272026Link
    Stablecoin users500 million5272026Link
    On-chain growth Asia-Pacific69%5272026Link
    On-chain growth Latin America63%5272026Link
    On-chain growth Sub-Saharan Africa52%5272026Link
    Country reach100+ countries5272026Link

    Price Chart

    Upcoming
    12/02/2026Earnings ReleaseRev: -
    EPS: -

    Why The Stock Moved

    Qualitative Assessment

    AI Analysis | Feedback

    Updated on 9/18/2026

    SkyAI (SKYA) stock has lost about 5% since 5/31/2026 because of the following key factors:

    1. Unproven Business Pivot to Agentic Finance and Associated Risks.

    SkyAI (SKYA) completed a significant business transformation during fiscal Q2 2026 (which ended June 30, 2026), pivoting from its legacy syringe-product distribution to an unproven agentic finance platform powered by a Solana digital asset treasury. The company's August 7, 2026, 10-Q filing explicitly highlighted new and material risks related to this strategic execution, including those stemming from the use of AI, cybersecurity exposure, and evolving AI regulatory landscapes.

    2. Shareholder Revolt and Significant Governance Concerns.

    Leading up to its annual meeting on September 18, 2026, SkyAI faced mounting pressure from a shareholder group, Bastion Trading (holding a 9.99% stake), and rejected acquirer Forward Industries. Both parties urged shareholders to withhold votes for all five director nominees and to reject a proposed 2026 Equity Incentive Plan, which would authorize 5.145 million new shares, leading to over 7% dilution. Concerns were also raised about related-party transactions and the adoption of a "poison pill" plan without a shareholder vote.

    Show more
    Updated on 9/18/2026

    SkyAI (SKYA) stock has lost about 5% since 5/31/2026 because of the following key factors:

    1. Unproven Business Pivot to Agentic Finance and Associated Risks.

    SkyAI (SKYA) completed a significant business transformation during fiscal Q2 2026 (which ended June 30, 2026), pivoting from its legacy syringe-product distribution to an unproven agentic finance platform powered by a Solana digital asset treasury. The company's August 7, 2026, 10-Q filing explicitly highlighted new and material risks related to this strategic execution, including those stemming from the use of AI, cybersecurity exposure, and evolving AI regulatory landscapes.

    2. Shareholder Revolt and Significant Governance Concerns.

    Leading up to its annual meeting on September 18, 2026, SkyAI faced mounting pressure from a shareholder group, Bastion Trading (holding a 9.99% stake), and rejected acquirer Forward Industries. Both parties urged shareholders to withhold votes for all five director nominees and to reject a proposed 2026 Equity Incentive Plan, which would authorize 5.145 million new shares, leading to over 7% dilution. Concerns were also raised about related-party transactions and the adoption of a "poison pill" plan without a shareholder vote.

    3. Nasdaq Listing Non-Compliance.

    SkyAI received a notice from the Nasdaq Stock Market regarding non-compliance with an equity listing rule. As reported on September 19, 2026, the company's stockholders' equity was negative $497,307 in its Quarterly Report for fiscal Q2 2026 (ended June 30, 2026), falling short of the Nasdaq Capital Market's minimum requirement of $2.5 million. This deficiency signals financial instability and poses a risk to its listing status.

    Show less
    Holding a concentrated position? Know your true downside before the momentum shifts.
    Protect Your Wealth →

    Stock Movement Drivers

    Fundamental Drivers

    The -7.4% change in SKYA stock from 5/31/2026 to 9/20/2026 was primarily driven by a -43.9% change in the company's Total Revenues ($ Mil).
    (LTM values as of)53120269202026Change
    Stock Price ($)1.831.70-7.4%
    Change Contribution By: 
    Total Revenues ($ Mil)00-43.9%
    P/S Multiple428.0701.663.9%
    Shares Outstanding (Mil)73720.7%
    Cumulative Contribution-7.4%

    LTM = Last Twelve Months as of date shown

    Market Drivers

    5/31/2026 to 9/20/2026
    ReturnCorrelation
    SKYA-7.4% 
    Market (SPY)0.9%24.1%
    Sector (XLK)-0.7%14.9%

    Fundamental Drivers

    null
    null

    Market Drivers

    2/28/2026 to 9/20/2026
    ReturnCorrelation
    SKYA  
    Market (SPY)11.6%23.4%
    Sector (XLK)36.8%12.9%

    Fundamental Drivers

    null
    null

    Market Drivers

    8/31/2025 to 9/20/2026
    ReturnCorrelation
    SKYA  
    Market (SPY)19.4%23.4%
    Sector (XLK)45.1%12.9%

    Fundamental Drivers

    null
    null

    Market Drivers

    8/31/2023 to 9/20/2026
    ReturnCorrelation
    SKYA  
    Market (SPY)75.6%23.4%
    Sector (XLK)119.9%12.9%

    Return vs. Risk

    Price Returns Compared

     202120222023202420252026Total [1]
    Returns
    SKYA Return------23%-23%
    Peers Return-9%-46%75%13%-16%10%-10%
    S&P 500 Return27%-19%24%23%16%12%103%

    Monthly Win Rates [3]
    SKYA Win Rate-----60% 
    Peers Win Rate49%35%58%58%50%53% 
    S&P 500 Win Rate75%42%67%75%67%44% 

    Max Drawdowns [4]
    SKYA Max Drawdown------ 
    Peers Max Drawdown-42%-56%-34%-37%-41%-38% 
    S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 

    [1] Cumulative total returns since the beginning of 2021
    [2] Peers: GEN, S, PATH, CVLT, AI.
    [3] Win Rate = % of calendar months in which monthly returns were positive
    [4] Max drawdown represents maximum peak-to-trough decline within a year
    [5] 2026 data is for the year up to 9/18/2026 (YTD)

    How Low Can It Go

    SKYA has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.

    EventXLKS&P 500
    2025 US Tariff Shock
      % Loss-25.7%-18.8%
      % Gain to Breakeven34.5%23.1%
      Time to Breakeven65 days79 days
    2024 Yen Carry Trade Unwind
      % Loss-17.0%-7.8%
      % Gain to Breakeven20.4%8.5%
      Time to Breakeven92 days18 days
    Summer-Fall 2023 Five Percent Yield Shock
      % Loss-10.0%-9.5%
      % Gain to Breakeven11.2%10.5%
      Time to Breakeven15 days24 days
    2022 Inflation Shock & Fed Tightening
      % Loss-33.1%-24.5%
      % Gain to Breakeven49.5%32.4%
      Time to Breakeven246 days427 days
    2020 COVID-19 Crash
      % Loss-31.2%-33.7%
      % Gain to Breakeven45.2%50.9%
      Time to Breakeven78 days140 days
    Q4 2018 Fed Policy Error / Growth Scare
      % Loss-23.8%-19.2%
      % Gain to Breakeven31.2%23.8%
      Time to Breakeven100 days105 days

    Compare to GEN, PATH, S, CVLT, BTLN

    In The Past

    State Street Technology Select Sector SPDR ETF's stock fell -25.7% during the 2025 US Tariff Shock. Such a loss loss requires a 34.5% gain to breakeven.

    Preserve Wealth

    Limiting losses and compounding gains is essential to preserving wealth.

    Asset Allocation

    Actively managed asset allocation strategies protect wealth. Learn more.

    SKYA has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.

    EventXLKS&P 500
    2025 US Tariff Shock
      % Loss-25.7%-18.8%
      % Gain to Breakeven34.5%23.1%
      Time to Breakeven65 days79 days
    2022 Inflation Shock & Fed Tightening
      % Loss-33.1%-24.5%
      % Gain to Breakeven49.5%32.4%
      Time to Breakeven246 days427 days
    2020 COVID-19 Crash
      % Loss-31.2%-33.7%
      % Gain to Breakeven45.2%50.9%
      Time to Breakeven78 days140 days
    Q4 2018 Fed Policy Error / Growth Scare
      % Loss-23.8%-19.2%
      % Gain to Breakeven31.2%23.8%
      Time to Breakeven100 days105 days
    2008-2009 Global Financial Crisis
      % Loss-51.5%-53.4%
      % Gain to Breakeven106.2%114.4%
      Time to Breakeven797 days1085 days

    Compare to GEN, PATH, S, CVLT, BTLN

    In The Past

    State Street Technology Select Sector SPDR ETF's stock fell -25.7% during the 2025 US Tariff Shock. Such a loss loss requires a 34.5% gain to breakeven.

    Preserve Wealth

    Limiting losses and compounding gains is essential to preserving wealth.

    Asset Allocation

    Actively managed asset allocation strategies protect wealth. Learn more.

    About SkyAI (SKYA)

    SkyAI (SKYA) operates as a medical device company, specializing in the entire lifecycle of safety syringe products. Its operations encompass the research, design, development, manufacturing, distribution, and sale of these essential medical devices, primarily serving the market within the United States.

    The company's flagship product is Sharps Provensa, an advanced ultra-low waste space syringe. This innovative design is specifically engineered for the efficient administration of various vaccines and a wide range of injectable medications, addressing the critical need to minimize waste in medical settings.

    SkyAI's primary customers are healthcare providers, medical institutions, and public health initiatives involved in vaccination efforts and other forms of medication delivery. By providing specialized safety syringes, the company plays a role in supporting safe and efficient medical practices across the U.S. healthcare sector.

    AI Analysis | Feedback

    1. A specialized Becton Dickinson (BD) focusing on innovative safety syringes.

    2. Like a niche medical device company, similar to a focused division of a larger healthcare firm like Johnson & Johnson, but dedicated to advanced safety syringe technology.

    AI Analysis | Feedback

    • Safety syringe products: These are medical devices designed to prevent needlestick injuries and ensure safe handling of needles.
    • Sharps Provensa: An ultra-low waste space syringe specifically designed for the administration of various vaccines and injectable medications, aiming to minimize medication waste.

    AI Analysis | Feedback

    Sharps Technology Inc. (symbol: SKYA), which trades under the symbol SKYA, primarily sells its safety syringe products to other companies and institutions, not individuals. Its major customers whose names can be identified include:
    • Nephros, Inc. (Symbol: NEPH): A publicly traded medical device company that serves as an exclusive distributor for Sharps Technology's products in the United States and Canada. As a distributor, Nephros, Inc. acts as a significant direct customer.
    Sharps Technology also has a long-term supply agreement with a leading global healthcare company, which represents a major customer, though its name has not been disclosed due to confidentiality agreements. Additionally, Sharps Technology's target customer base, often reached through distribution partners, includes:
    • Other medical device distributors
    • Healthcare providers such as hospitals, clinics, and pharmacies
    • Pharmaceutical companies and vaccine manufacturers
    • Government agencies for public health programs

    AI Analysis | Feedback

    • Nephron Pharmaceuticals Corporation

    AI Analysis | Feedback

    The management team members of SkyAI (SKYA) are as follows:

    Paul K. Danner, Principal Executive Officer & Board Member

    Mr. Danner is a seasoned public company leader with over three decades of executive experience. He has served as chief executive of four Nasdaq-listed enterprises, where he successfully executed initial public offerings, led M&A-driven growth strategies, and raised significant capital. He also held senior board leadership roles across six different public companies. Before his role at Sharps Technology (now SkyAI), Mr. Danner was chief financial and administrative officer of PAY2DAY Solutions, Inc. dba Authvia since 2013 and served as chief executive officer of Alliance MMA, Inc. from 2016 to 2018. He is also a retired U.S. Navy Captain.

    Arthur Levine, Interim Chief Financial Officer

    Mr. Levine was appointed as interim Chief Financial Officer for SkyAI (formerly Sharps Technology) in February 2026. He is a Certified Public Accountant and a Wharton graduate, bringing prior CFO experience from NextNRG, Inc. and Sensus Healthcare.

    Alice Zhang, Chief Investment Officer & Board Member

    Ms. Zhang possesses extensive experience in scaling businesses across the Global South. She co-founded Jambo Technology, a prominent Web3 mobile infrastructure that has expanded its reach to users in over 100 countries and is built on Solana.

    Matthew A. Carter, Vice President of Finance & Accounting

    Braden Miller, Vice President, Operations

    AI Analysis | Feedback

    Key Risks to SkyAI (SKYA)

    The primary risks to SkyAI, Inc. (SKYA), formerly Sharps Technology Inc., stem from its recent and significant pivot from a medical device company to a business primarily focused on a digital asset treasury strategy and the development of an "Agentic Finance" platform for the Global South.
    1. Volatility of Digital Assets: SkyAI's financial performance and asset base are heavily dependent on the market price of Solana (SOL) and other digital assets. The company holds a significant treasury of SOL and generates substantial revenue from staking these digital assets. Fluctuations or significant declines in the value of SOL or other digital assets could materially and adversely impact the company's financial health, operating results, and overall valuation.
    2. Execution Risk of the Agentic Finance Strategy: SkyAI has recently rebranded and shifted its strategic focus to building an "Agentic Finance platform serving the Global South". This represents an ambitious and unproven business model in a complex and diverse market. The successful execution of this new strategy, including the development of technology, establishment of partnerships, and achieving market adoption, poses significant risks. Challenges in implementing this strategy could hinder the company's ability to generate sustainable revenue and achieve profitability from its new core business.
    3. Regulatory and Legal Environment for Digital Assets and Fintech: Operating with a digital asset treasury and developing an "Agentic Finance" platform, particularly in the Global South, exposes SkyAI to a dynamic and often uncertain regulatory and legal landscape. Changes in regulations pertaining to cryptocurrencies, blockchain technology, decentralized finance, and international financial services in various jurisdictions could lead to increased compliance costs, restrict business operations, or even render certain aspects of the business model untenable. The complexity and evolving nature of these regulations present a substantial risk to the company's future operations and growth.

    AI Analysis | Feedback

    The clear emerging threat for Sharps Technology Inc. (SKYA) is the advancement and increasing adoption of needle-free injection systems. These systems offer an alternative method for administering vaccines and injectable medications without the use of a traditional needle and syringe, potentially rendering conventional syringe products, including safety syringes, less relevant or obsolete for various applications. This technology directly addresses concerns about needle-stick injuries, patient discomfort, and could potentially offer comparable or superior waste reduction for specific drug delivery scenarios, similar to how streaming services fundamentally changed media consumption compared to physical rentals.

    AI Analysis | Feedback

    null

    AI Analysis | Feedback

    null

    AI Analysis | Feedback

    Share Repurchases

    • SkyAI, Inc. (formerly Sharps Technology Inc.) announced a stock repurchase program on October 2, 2025, to acquire up to $100 million of its outstanding common stock.

    Share Issuance

    • The number of outstanding shares significantly increased by 271,952.24% in one year, with 42.32 million shares outstanding as of a recent date (likely March 31, 2026).
    • Sharps Technology Inc. announced a private placement exceeding $400 million, involving the sale of common stock and warrants, to establish its Solana digital asset treasury strategy, expected to close around August 28, 2025.
    • As of May 15, 2026, certain affiliates reported beneficial ownership including pre-funded warrants exercisable for 4,234,615 shares and stapled warrants exercisable for 5,384,615 shares.

    Inbound Investments

    • SkyAI, Inc. (as Sharps Technology, Inc.) received $400 million in funding from a group of investors in a transaction that closed on August 28, 2025, to establish its Solana digital asset treasury strategy.
    • The company also received $3.8 million in funding, with the transaction closing on February 6, 2023.

    Outbound Investments

    • Sharps Technology, Inc. completed the acquisition of Safegard Medical (Hungary) Kft. for $2.5 million on July 8, 2022.

    Capital Expenditures

    • No specific dollar value of traditional capital expenditures on property, plant, and equipment was prominently disclosed for the last 3-5 years. The company's recent strategic focus, as SkyAI, Inc., is on building an AI-driven agentic finance platform and accumulating SOL tokens as part of its digital asset treasury strategy.

    Peer Outperformance in Systems Software

    null
    Share of Systems Software constituents that SKYA has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
    1Y
    —
    insufficient peer history
    3Y
    —
    insufficient peer history
    5Y
    —
    insufficient peer history
    null
    Median price return by industry across the Information Technology sector, ranked by 5Y. Systems Software is SKYA's own industry. Use this to see which corners of the sector have carried the returns.
    Industry Names 1Y med3Y med5Y med Top 3 by 5Y
    Electronic Manufacturing Services 9 54.5%185.9%278.9% TTMI 845% · FLEX 734% · SANM 435%
    Technology Distributors 9 30.1%72.9%99.7% CLMB 337% · AVT 199% · SNX 156%
    Semiconductor Materials & Equipment 26 90.9%83.7%97.5% AXTI 792% · AEHR 738% · KLAC 421%
    Communications Equipment 36 16.3%86.8%75.8% AAOI 1451% · FEIM 1030% · LITE 1005%
    Electronic Components 26 31.5%70.6%70.4% CLS 4032% · BELFA 1349% · COHR 435%
    Technology Hardware, Storage & Peripherals 20 31.9%90.0%47.2% DELL 1150% · STX 1112% · WDC 969%
    Semiconductors 55 23.7%33.9%40.8% POET 1815% · MU 1344% · NVDA 951%
    Internet Services & Infrastructure 6 7.5%49.3%33.5% DOCN 64% · VRSN 44% · GDDY 38%
    Electronic Equipment & Instruments 26 -16.0%9.2%-10.0% PI 225% · OSIS 117% · ACFN 108%
    IT Consulting & Other Services 28 -24.6%-9.9%-29.0% CHRN 537268% · APLD 1265% · TSSI 669%
    Application Software 123 -30.5%-13.3%-45.3% VIDA 176264% · INLX 5435% · PLTR 567%
    Systems Software ← 68 -19.6%12.4%-54.0% QNC 478% · ZETA 406% · PANW 361%
    Median of constituents with a full price history over each window. Top names are unfiltered by size in this render.

    Recent Active Movers

    Top Gainers

    TickerCompanyMkt Cap (B)1W RtnYTD Rtn
    SDGRSchrodinger2.252.6%62.3%
    PSPershing Square19.932.3%106.6%
    BBNXBeta Bionics1.032.1%-28.2%
    TEMTempus AI14.031.9%31.8%
    SECZSecuritize1.631.3%-11.7%
    TWSTTwist Bioscience10.431.3%426.5%
    EMATEvolution Metals & Technologies2.530.5%-81.1%
    GEMIGemini Space Station0.730.3%-41.4%
    RUMRumble2.626.8%43.8%
    ALMRAlamar Biosciences2.025.0%58.4%

    Top Losers

    TickerCompanyMkt Cap (B)1W RtnYTD Rtn
    ADBTAdvasa0.1-47.1%-98.0%
    SWMRSwarmer0.4-39.4%-22.6%
    ALHCAlignment Healthcare1.7-33.8%-57.7%
    XENEXenon Pharmaceuticals4.0-32.2%-11.3%
    FLNCFluence Energy1.0-26.3%-63.0%
    ENVAEnova International4.3-21.8%11.1%
    VYXNCR Voyix0.9-21.2%-33.9%
    ARWRArrowhead Pharmaceuticals9.5-19.8%0.1%
    DMRADamora Therapeutics1.4-19.6%-1.8%
    IONSIonis Pharmaceuticals7.4-18.0%-43.8%

    Top Gainers

    TickerCompanyMkt Cap (B)1M RtnYTD Rtn
    SECZSecuritize1.680.1%-11.7%
    FWDIForward Industries0.755.9%16.5%
    PURRHyperliquid Strategies1.750.1%295.8%
    GEMIGemini Space Station0.747.8%-41.4%
    MSTRStrategy54.347.6%1.3%
    SMTCSemtech17.247.6%151.1%
    CVICVR Energy5.446.3%112.4%
    SDGRSchrodinger2.246.2%62.3%
    EMATEvolution Metals & Technologies2.541.1%-81.1%
    ACVAACV Auctions1.840.3%30.7%

    Top Losers

    TickerCompanyMkt Cap (B)1M RtnYTD Rtn
    ALMSAlumis1.0-67.6%-20.4%
    IESCIES12.8-47.5%-17.2%
    SWMRSwarmer0.4-46.9%-22.6%
    RAREUltragenyx Pharmaceutical1.5-44.7%-36.9%
    TTANServiceTitan5.2-42.1%-48.3%
    FLNCFluence Energy1.0-39.4%-63.0%
    KRMNKarman4.7-38.6%-51.1%
    XENEXenon Pharmaceuticals4.0-36.2%-11.3%
    DYNDyne Therapeutics2.8-36.1%-12.5%
    DKSDick's Sporting Goods10.7-36.1%-37.5%

    More From Trefis

    Research & Analysis

    Invest in Strategies

    Wealth Management

    Peer Comparisons

    Peers to compare with:

    Financials

    SKYAGENSPATHCVLTAIMedian
    NameSkyAI Gen Digi.Sentinel.UiPath CommVaul.C3.ai  
    Mkt Price1.7029.0122.5113.39144.5410.4817.95
    Mkt Cap0.117.47.77.06.0-7.0
    Rev LTM05,0791,0991,7211,216-1,216
    Op Inc LTM-192,174-296153109-109
    FCF LTM-2021,54831363258-258
    FCF 3Y Avg-721,66012333218-218
    CFO LTM-141,57057373265-265
    CFO 3Y Avg-81,67938347223-223

    Growth & Margins

    SKYAGENSPATHCVLTAIMedian
    NameSkyAI Gen Digi.Sentinel.UiPath CommVaul.C3.ai  
    Rev Chg LTM28.0%20.2%21.1%15.0%15.5%-20.2%
    Rev Chg 3Y Avg-12.8%28.2%14.5%15.8%-15.2%
    Rev Chg Q-100.0%6.3%20.6%13.4%11.4%-11.4%
    QoQ Delta Rev Chg LTM-43.9%1.6%4.7%2.9%2.7%-2.7%
    Op Inc Chg LTM-308.2%31.0%9.9%430.0%20.5%-20.5%
    Op Inc Chg 3Y Avg-84.8%18.5%10.1%174.7%21.3%-18.5%
    Op Mgn LTM-10,757.7%42.8%-26.9%8.9%9.0%-8.9%
    Op Mgn 3Y Avg-37.9%-35.8%-2.7%9.1%-3.2%
    QoQ Delta Op Mgn LTM-6,163.4%-0.3%2.3%2.8%0.0%-0.0%
    CFO/Rev LTM-8,259.4%30.9%5.2%21.7%21.8%-21.7%
    CFO/Rev 3Y Avg-39.4%4.0%22.7%21.5%-22.1%
    FCF/Rev LTM-115,934.5%30.5%2.8%21.1%21.3%-21.1%
    FCF/Rev 3Y Avg-39.0%1.0%21.8%21.0%-21.4%

    Valuation

    SKYAGENSPATHCVLTAIMedian
    NameSkyAI Gen Digi.Sentinel.UiPath CommVaul.C3.ai  
    Mkt Cap0.117.47.77.06.0-7.0
    P/S703.63.47.04.04.9-4.9
    P/Op Inc-6.58.0-26.045.554.9-8.0
    P/EBIT-0.48.4-26.045.558.3-8.4
    P/E-0.316.5-22.619.287.5-16.5
    P/CFO-8.511.1134.118.622.6-18.6
    Total Yield-324.3%7.8%-4.4%5.2%1.1%-1.1%
    Dividend Yield0.0%1.8%0.0%0.0%0.0%-0.0%
    FCF Yield 3Y Avg-10.4%0.2%5.2%3.6%-4.4%
    D/E0.00.50.00.00.2-0.0
    Net D/E-0.10.4-0.1-0.2-0.0--0.1

    Returns

    SKYAGENSPATHCVLTAIMedian
    NameSkyAI Gen Digi.Sentinel.UiPath CommVaul.C3.ai  
    1M Rtn30.4%0.3%6.2%-18.3%8.0%1.7%4.0%
    3M Rtn43.6%20.5%49.9%30.4%11.2%1.7%25.4%
    6M Rtn-4.2%39.7%58.9%11.0%82.0%23.7%31.7%
    12M Rtn-4.2%2.1%17.9%12.8%-25.7%-41.5%-1.1%
    3Y Rtn-4.2%62.1%41.5%-18.0%113.6%-59.1%18.6%
    1M Excs Rtn34.2%6.1%6.3%-14.4%6.0%1.7%6.0%
    3M Excs Rtn41.6%18.5%47.9%28.4%9.2%-0.3%23.4%
    6M Excs Rtn-20.0%26.7%38.8%-6.4%65.3%5.1%15.9%
    12M Excs Rtn-20.1%-12.7%6.7%-2.6%-39.6%-55.1%-16.4%
    3Y Excs Rtn-75.5%-9.5%-36.8%-97.5%39.6%-133.5%-56.1%

    Comparison Analyses

    null

    Financials

    $ Mil | FY: 12/312026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q3
    Period End6/30/20263/31/202612/31/20259/30/20256/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/2023
    Filing Date8/7/20265/14/20263/31/202611/14/20258/13/20255/15/20253/27/202511/14/20248/14/20245/14/20243/29/202411/14/2023
    Key Financials Quarterly            
    Total Revenue00-0000000000
    Ebitda-6-5-154-110-1-12-2-2-2-3-2
    Operating Income-6-5102-111-1-10-2-2-2-3-2
    Net Income-23-86-183-10542-5-2-2-1-3-2
    EPS-0.32-1.19-6.30-4.333.5838.63-861.34-379.55-643.64-347.50-1080.00-1131.00
    Key Financials TTM            
    Total Revenue TTM000000000000
    Ebitda TTM-275-270-267-111-2-3-3-8-8-9-9-9
    Operating Income TTM-19-14-11-113-5-5-6-9-9-10-10-10
    Net Income TTM-398-371-283-104-1-6-9-8-8-9-10-8
    Growth Rates Quarterly            
    Total Revenue Growth-100.0%-----------
    EBITDA Growth-329.9%-247.1%-7048.5%-5960.2%20.8%20.6%182.5%15.4%24.9%21.6%-10.1%-28.8%
    Operating Income Growth-314.9%-234.7%48020.2%-5390.6%25.9%26.0%107.3%14.6%24.1%20.4%-3.6%-31.2%
    Net Income Growth-754.1%-4571.1%-3935.3%-6151.0%269.3%296.3%-45.9%16.7%19.3%53.5%-265.1%15.7%
    Margins Quarterly            
    EBITDA Margin--2357.0%--131950.4%-1005.7%-------
    Operating Income Margin--2368.6%--132317.3%-1046.2%-------
    Net Income Margin--44734.5%--125963.6%2615.6%-------
    Cash & Debt            
    Total Cash12121011812121136
    Total Debt003800420000
    Net Debt / (Cash)-12-12-7-3-8-123-0-1-1-3-6
    Cash Flows Quarterly            
    FCF from Operations-3-31-9-1-11-2-2-2-2-2
    Cash Flows TTM            
    FCF from Operations TTM-14-12-11-11-3-4-4-8-8-8-9-8
    Returns to Shareholders Quarterly            
    Dividends000000000000
    Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
    Return on Invested Capital (ROIC) Quarterly            
    ROIC-4.1%-3.2%71.3%-78.4%-16.2%-17.7%2.2%-22.2%-22.6%-23.2%-38.8%-34.8%
    Return on Invested Capital (ROIC) TTM            
    ROIC TTM-3.3%-2.5%-1.9%-20.1%-13.1%-16.5%-14.1%-24.0%-26.6%-30.3%-33.7%-37.0%

    Segment Financials

    Revenue by Segment
    $ Mil20252024202320222021
    Medical Device Packaging00   
    Corporate00   
    Digital Assets0    
    Single Segment  000
    Total00000


    Operating Income by Segment
    $ Mil20252024
    Medical Device Packaging-10
    Corporate-150
    Digital Assets-254 
    Total-2700


    Net Income by Segment
    $ Mil202520242023
    Corporate-10-4 
    Medical Device Packaging-13-5 
    Digital Assets-259  
    Single Segment  -10
    Total-283-9-10


    Assets by Segment
    $ Mil20252024202320222021
    Digital Assets257    
    Corporate112   
    Medical Device Packaging11   
    Single Segment  12126
    Total269312126


    Price Behavior

    null
    SKYA Betas & Captures as of 8/31/2026

     1M2M3M6M1Y3Y
    Beta1.631.161.710.301.22-0.16
    Up Beta-3.28-1.731.911.57-0.75-0.69
    Down Beta-2.332.061.62-0.41-4.33-1.22
    Up Capture425%283%84%39%18%2%
    Bmk +ve Days10213268138427
    Stock +ve Days81824252525
    Down Capture499%116%209%122%76%42%
    Bmk -ve Days11213259113324
    Stock -ve Days122338383838

    [1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
    Based On 1-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with SKYA
    SKYA-4.3%115.2%0.38-
    Sector ETF (XLK)40.5%26.4%1.2512.9%
    Equity (SPY)16.9%12.9%0.9423.4%
    Gold (GLD)19.1%29.3%0.6044.2%
    Commodities (DBC)46.3%20.6%1.73-1.4%
    Real Estate (VNQ)4.9%13.6%0.10-2.6%
    Bitcoin (BTCUSD)-30.6%44.3%-0.7065.0%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How
    Based On 5-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with SKYA
    SKYA-0.9%115.2%0.38-
    Sector ETF (XLK)20.2%25.9%0.6912.9%
    Equity (SPY)12.9%17.2%0.5723.4%
    Gold (GLD)19.1%18.8%0.8344.2%
    Commodities (DBC)11.2%19.5%0.45-1.4%
    Real Estate (VNQ)1.1%18.8%-0.05-2.6%
    Bitcoin (BTCUSD)12.5%52.5%0.4265.0%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How
    Based On 10-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with SKYA
    SKYA-0.4%115.2%0.38-
    Sector ETF (XLK)24.4%25.0%0.8812.9%
    Equity (SPY)15.1%18.0%0.7223.4%
    Gold (GLD)12.1%16.4%0.6144.2%
    Commodities (DBC)8.3%18.1%0.37-1.4%
    Real Estate (VNQ)4.4%20.7%0.18-2.6%
    Bitcoin (BTCUSD)62.6%66.2%1.0265.0%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How

    Short Interest

    Short Interest: As Of Date8312026
    Short Interest: Shares Quantity0.6 Mil
    Short Interest: % Change Since 815202612.3%
    Average Daily Volume0.6 Mil
    Days-to-Cover Short Interest1
    Basic Shares Quantity72.1 Mil
    Short % of Basic Shares0.8%

    Earnings Returns History

    Updated 6/2/2026
    Expand for More
     Forward Returns
    Earnings Date1D Returns5D Returns21D Returns
    SUMMARY STATS   
    # Positive000
    # Negative000
    Median Positive   
    Median Negative   
    Max Positive   
    Max Negative   
     Collapse to Preview
     Forward Returns
    Earnings Date1D Returns5D Returns21D Returns
    SUMMARY STATS   
    # Positive000
    # Negative000
    Median Positive   
    Median Negative   
    Max Positive   
    Max Negative   

    SEC Filings

    Expand for More
    Report DateFiling DateFiling
    06/30/202608/07/202610-Q
    03/31/202605/14/202610-Q
    12/31/202503/31/202610-K
    09/30/202511/14/202510-Q
    06/30/202508/13/202510-Q
    03/31/202505/15/202510-Q
    12/31/202403/27/202510-K
    09/30/202411/14/202410-Q
    06/30/202408/14/202410-Q
    03/31/202405/14/202410-Q
    12/31/202303/29/202410-K
    09/30/202311/14/202310-Q
    06/30/202308/14/202310-Q
    03/31/202305/15/202310-Q
    12/31/202203/31/202310-K
    09/30/202211/14/202210-Q
     Collapse to Preview
    Report DateFiling DateFiling
    06/30/202608/07/202610-Q
    03/31/202605/14/202610-Q
    12/31/202503/31/202610-K
    09/30/202511/14/202510-Q
    06/30/202508/13/202510-Q
    03/31/202505/15/202510-Q
    12/31/202403/27/202510-K
    09/30/202411/14/202410-Q
    06/30/202408/14/202410-Q
    03/31/202405/14/202410-Q
    12/31/202303/29/202410-K
    09/30/202311/14/202310-Q
    06/30/202308/14/202310-Q
    03/31/202305/15/202310-Q
    12/31/202203/31/202310-K
    09/30/202211/14/202210-Q
    06/30/202208/15/202210-Q
    03/31/202205/25/202210-Q
    12/31/202104/15/2022424B4

    Industry Resources

    External Quote Links


    Prefer one of these to Trefis? Tell us why.
    Core Cache Last Updated: 9/20/2026